Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A M Lefer

Showing results (221-230 of 489) with videos related to

Pageof 49
Sort By:
Circulation|December 1, 1980
Thromboxane A2, prostacyclin and aspirin: effects on vascular tone and platelet aggregationJ B Smith, H Araki, A M Lefer
Circulatory Shock|February 1, 1992
Effects of adenosine, an adenosine-A1 antagonist, and their combination in splanchnic occlusion shock in ratsA Karasawa, J A Rochester, A M Lefer
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|March 1, 1976
Factors influencing nonspecific binding of glucocorticoids in myocardial tissueA C Beardsley, M Okuda, A M Lefer
The Journal of Pharmacology and Experimental Therapeutics|February 12, 1998
Heparinase III exerts endothelial and cardioprotective effects in feline myocardial ischemia-reperfusion injuryR Hayward, T O Nossuli, A M Lefer
International Archives of Allergy and Applied Immunology|January 1, 1986
Inhibition of the platelet activating factor mediated component of guinea pig anaphylaxis by receptor antagonistsH Darius, J B Smith, A M Lefer
Resuscitation|July 1, 1988
Efficacy of a combination thromboxane receptor antagonist and lipoxygenase inhibitor in traumatic shockM A Levitt, G Stahl, A M Lefer
Cardiovascular Research|February 13, 2001
Vascular effects of HMG CoA-reductase inhibitors (statins) unrelated to cholesterol lowering: new concepts for cardiovascular diseaseA M Lefer, R Scalia, D J Lefer
The American Journal of Physiology|March 1, 1996
Novel recombinant serpin, LEX-032, attenuates myocardial reperfusion injury in catsJ A Delyani, T Murohara, A M Lefer
Shock (Augusta, Ga.)|October 1, 1995
Beneficial effects of LEX032, a novel recombinant serine protease inhibitor, in murine traumatic shockR Scalia, T W Gauthier, A M Lefer
Journal of Cardiovascular Pharmacology|September 1, 1983
Protection of ischemic cat myocardium by CGS-13080, a selective potent thromboxane A2 synthesis inhibitorS E Burke, G DiCola, A M Lefer
Pageof 49

Showing results (221-230 of 489) with videos related to

Sort By:
Pageof 49
Circulation|December 1, 1980
Thromboxane A2, prostacyclin and aspirin: effects on vascular tone and platelet aggregationJ B Smith, H Araki, A M Lefer
Circulatory Shock|February 1, 1992
Effects of adenosine, an adenosine-A1 antagonist, and their combination in splanchnic occlusion shock in ratsA Karasawa, J A Rochester, A M Lefer
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|March 1, 1976
Factors influencing nonspecific binding of glucocorticoids in myocardial tissueA C Beardsley, M Okuda, A M Lefer
The Journal of Pharmacology and Experimental Therapeutics|February 12, 1998
Heparinase III exerts endothelial and cardioprotective effects in feline myocardial ischemia-reperfusion injuryR Hayward, T O Nossuli, A M Lefer
International Archives of Allergy and Applied Immunology|January 1, 1986
Inhibition of the platelet activating factor mediated component of guinea pig anaphylaxis by receptor antagonistsH Darius, J B Smith, A M Lefer
Resuscitation|July 1, 1988
Efficacy of a combination thromboxane receptor antagonist and lipoxygenase inhibitor in traumatic shockM A Levitt, G Stahl, A M Lefer
Cardiovascular Research|February 13, 2001
Vascular effects of HMG CoA-reductase inhibitors (statins) unrelated to cholesterol lowering: new concepts for cardiovascular diseaseA M Lefer, R Scalia, D J Lefer
The American Journal of Physiology|March 1, 1996
Novel recombinant serpin, LEX-032, attenuates myocardial reperfusion injury in catsJ A Delyani, T Murohara, A M Lefer
Shock (Augusta, Ga.)|October 1, 1995
Beneficial effects of LEX032, a novel recombinant serine protease inhibitor, in murine traumatic shockR Scalia, T W Gauthier, A M Lefer
Journal of Cardiovascular Pharmacology|September 1, 1983
Protection of ischemic cat myocardium by CGS-13080, a selective potent thromboxane A2 synthesis inhibitorS E Burke, G DiCola, A M Lefer
Pageof 49